Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Bioinformatic Approach of B and T Cell Epitopes of PLD and CP40 Proteins of Corynebacterium pseudotuberculosis ovis Mexican Isolate 2J-L towards a Peptide-Based Vaccine.
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- Author(s): Rodríguez-Domínguez, Maria Carla1 (AUTHOR) ; Montes-de-Oca-Jiménez, Roberto1,2 (AUTHOR) ; Vázquez-Chagoyán, Juan Carlos1 (AUTHOR) ; Rivadeneira-Barreiro, Pilar Eliana3 (AUTHOR) ; Zambrano-Rodríguez, Pablo Cleomenes3 (AUTHOR) ; Ruiz-Riva-Palacio, Martha Elba2 (AUTHOR); Gutiérrez-Castillo, Adriana del Carmen1 (AUTHOR) ; de-Castro-Soares, Siomar4 (AUTHOR) ; Vieyra-Reyes, Patricia1 (AUTHOR); Arteaga-Troncoso, Gabriel5,6 (AUTHOR)
- Source:
International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p270. 19p.
- Subject Terms:
- Additional Information
- Subject Terms:
- Abstract:
Mapping B and T cell epitopes constitutes an important action for peptide vaccine design. PLD and CP40 virulence factors of Corynebacterium pseudotuberculosis biovar ovis, a causal agent of Caseous Lymphadenitis, have been evaluated in a murine model as good candidates for vaccine development. Therefore, the goal of this work was to in silico analyze B and T cell epitopes of the PLD and CP40 proteins of a Mexican isolate of Corynebacterium pseudotuberculosis ovis. The Immune Epitope Data Base and Resource website was employed to predict the linear and conformational B-cell, T CD4+, and T CD8+ epitopes of PLD and CP40 proteins of Corynebacterium pseudotuberculosis ovis Mexican strain 2J-L. Fifty B cell epitopes for PLD 2J-L and forty-seven for CP40 2J-L were estimated. In addition, T CD4+ and CD8+ cell epitopes were predicted for PLD 2J-L (MHC I:16 epitopes, MHC II:10 epitopes) and CP40 2J-L (MHC I: 15 epitopes, MHC II: 13 epitopes). This study provides epitopes, paying particular attention to sequences selected by different predictor programs and overlap sequences as B and T cell epitopes. PLD 2J-L and CP40 2J-L protein epitopes may aid in the design of a promising peptide-based vaccine against Caseous Lymphadenitis in Mexico. [ABSTRACT FROM AUTHOR]
No Comments.